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Abstract
Entamoeba histolytica requires a dynamic actin cytoskeleton for intestinal and systemic
pathogenicity. Diaphanous-related formins represent an important family of actin regulators that
are activated by Rho GTPases. The E. histolytica genome encodes a large family of Rho GTPases
and three diaphanous-related formins, of which EhFormin1 is known to regulate mitosis and
cytokinesis in trophozoites. We demonstrate that EhFormin1 modulates actin polymerization
through its formin homology 2 (FH2) domain. Despite a highly divergent diaphanous
autoinhibitory domain, EhFormin1 is autoinhibited by an N- and C-terminal intramolecular
interaction, but activated upon binding of EhRho1 to the N-terminal domain tandem. A crystal
structure of the EhRho1·GTPγS/EhFormin1 complex illustrates an EhFormin1 conformation that
diverges from mammalian mDia1 and lacks a secondary interaction with a Rho insert helix. The
structural model also highlights residues required for specific recognition of the EhRho1 GTPase
and suggests that the molecular mechanisms of EhFormin1 autoinhibition and activation differ
from mammalian homologs.
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Entamoeba histolytica is the causative agent of amoebic colitis and systemic amoebiasis (1).
Infection by the parasite is spread endemically among poor populations of developing
countries, although outbreaks among travelers and susceptible populations occur in the
United States (1). Water-borne E. histolytica cysts cycle to the trophozoite form in the
human host, in some cases leading to destruction of the intestinal mucosa (amoebic colitis).
If untreated, trophozoites may enter the blood stream, leading to systemic amoebiasis
characterized by liver, lung, and brain abscesses (2). Many cellular processes critical to E.
histolytica pathogenesis, such as chemotaxis, adherence to intestinal epithelium, cell killing,
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phagocytosis, and penetration of the mucosa are dependent on a highly dynamic actin
cytoskeleton (3–5). E. histolytica expresses a relatively large number of Rho family small
GTPases (6, 7), conserved signaling molecules that are vital to coordination of actin
cytoskeletal rearrangements (8). Rho GTPases undergo a conformational change dominated
by switch regions upon exchange of GTP for GDP, allowing engagement of specific
downstream effectors (9). Overexpression of constitutively active versions of the Rho family
GTPases EhRacA or EhRacG in E. histolytica trophozoites impairs pathogenic processes
such as phagocytosis and surface receptor capping (10, 11). However, signaling mechanisms
by which the actin cytoskeleton of E. histolytica is regulated have not been elucidated in
molecular detail.
Formins constitute a major class of proteins that directly regulate actin filament formation
and thus cellular morphology, adhesion, and motility (12). Formins promote nucleation and
polymerization of unbranched actin filaments (13). The highly conserved formin homology
2 domain (FH2) forms a head-to-tail dimer that binds to the barbed ends of actin filaments,
catalyzing assembly through a processive capping mechanism (12, 14, 15). The FH2 domain
is commonly preceded by an unstructured, proline-rich formin homology 1 domain (FH1)
that engages profilin/actin complexes, thus recruiting G-actin monomers for incorporation
into a growing filament (12). Members of the Diaphanous-related formin (DRF) subfamily
also possess an N-terminal Rho GTPase binding domain (GBD) and a formin homology 3
domain (FH3) that, in turn, is composed of an Armadillo repeat-containing Diaphanous
inhibitory domain (DID) and a dimerization domain (13). C-terminal to the FH2 domain of
DRFs is a Diaphanous autoinhibitory domain (DAD) that forms intramolecular interactions
with the DID, maintaining the formin in an inactive state, as best characterized structurally
for the DRF mDia1 (16, 17). This autoinhibited conformation is released upon binding of
specific Rho family GTPases to the GBD-FH3 domain tandem, likely due to active DAD
displacement from its DID binding site by Rho-induced contingent folding of the GBD and
by the Rho GTPase itself (18, 19). Although mDia1 primarily engages one of its activating
GTPases, RhoC, through the switch regions, the last Armadillo repeat of the DID also
weakly contacts the signature Rho insert helix of RhoC (20). Mutation of residues at this
secondary interface leads to reduced RhoC/mDia1 affinity, but it is unclear whether the
interaction is important for formin activation per se (14).
E. histolytica possesses a family of eight formins, among which EhFormin1–3 are
Diaphanous-related (21). EhFormin1 and -2 are expressed in trophozoites and associated
with pseudopodia, pinocytic and phagocytic vesicles, and F-actin in response to serum. Both
formins are also co-localized with the microtubular assembly during mitosis (21).
Overexpression of EhFormin1 increases the number of binucleated cells and nuclear DNA
content, suggesting roles for EhFormin1 in mitosis and cytokinesis (21). A recent proteomic
characterization of E. histolytica cysts indicated that EhFormin1 is expressed during both the
encysted and trophozoite life cycle stages (22). We recently showed (7) that the GBD-FH3
domain tandem of EhFormin1 binds EhRho1 in a nucleotide state-dependent fashion, which
is typical of Rho GTPase/effector interactions. Furthermore, expression of constitutively
active EhRho1 in fibroblasts induced stress fiber formation (7), suggesting that EhRho1
might regulate actin filament formation in E. histolytica trophozoites through EhFormin1 or
other effectors. Crystal structures of EhRho1 in different nucleotide states highlighted a lack
of the signature Rho insert helix (7), suggesting that the EhRho1/EhFormin1 interaction
might differ from that of RhoC/mDia1 (20).
In the current study, we demonstrate that EhFormin1 regulates actin polymerization through
its FH2 domain. Despite considerable sequence divergence of the DAD motif and the DID
motif surface expected to bind the DAD, EhFormin1 is autoinhibited by interaction between
its N- and C-terminal domains. As in the case of mDia1, highly selective binding of EhRho1
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to the GBD-FH3 tandem is sufficient to activate EhFormin1. Finally, a crystal structure of
the EhRho1·GTPγS/EhFormin1 complex reveals a primary interface between EhRho1 and
the EhFormin1 GBD with similarities to that of RhoC/mDia1. However, the absence of a
Rho insert helix within EhRho1 and a large conformational difference in the DID of
EhFormin1 compared to mDia1 illustrate the lack of a secondary EhRho1/EhFormin1
binding site, in contrast with mammalian homologs.
Experimental Procedures
Protein purification
EhRho1, EhRacC, EhRacD, and EhRacD were cloned from E. histolytica genomic DNA by
PCR amplification as hexahistidine-tagged open-reading frame fusions, expressed in
BL21(DE3) E. coli, purified by nickel affinity and gel filtration chromatography, and loaded
with GTPγS as described previously for EhRho1 (7). EhFormin1 (UniProt C4M622) was
cloned from genomic DNA, and fragments were PCR amplified and subcloned with a
tobacco etch virus (TEV) protease-cleavable hexahistidine tag using ligation independent
cloning (23). Mutagenesis was performed using the two PCR method (24). All EhFormin1
fragments were expressed in B834 E. coli induced with 500 μM isopropyl-β-D-
thiogalactopyranoside (IPTG) for 14–16 hours at 20°C. For crystallization of the GBD-FH3
domain tandem, a selenium-containing derivative was produced by induction in minimal
media containing selenomethioine (Molecular Dimensions, Apopka, FL). Bacterial cells
were pelleted by centrifugation and resuspended in N1 buffer composed of 50 mM Tris pH
7.5, 250 mM NaCl, 10 mM imidazole, 1 mM DTT, and 5% (v/v) glycerol. Bacteria were
lysed using pressure homogenization with an Emulsiflex (Avestin; Ottawa, Canada).
Cellular lysates were cleared with centrifugation at 100,000 × g for 60 minutes at 4°C, and
the resulting supernatant was applied to a nickel-nitrilotriacetic acid (NTA) resin FPLC
column (FF HisTrap crude; GE Healthcare, Piscataway, NJ), washed with N1 buffer plus 20
mM imidazole before elution in N1 buffer with 300 mM imidazole. EhFormin1 GBD-FH3
tandem selenomethioine protein was pooled and dialyzed overnight in imidazole-free N1
buffer with His6-TEV protease to cleave the N-terminal affinity tag. The dialysate was then
passed over a second NTA column to remove TEV protease and uncleaved protein. All
EhFormin1 fragments were resolved using a calibrated size exclusion column (HiLoad
16/60 Superdex 200, GE Healthcare) in S200 buffer (50 mM HEPES pH 8.0, 150 mM NaCl,
and 5 mM DTT). All proteins were concentrated to 0.5 – 2 mM and snap frozen in a dry ice/
ethanol bath for storage at −80°C.
Actin for in vitro polymerization assays was purified from rabbit skeletal muscle acetone
powder as described previously (25), and further purified with gel filtration chromatography.
The actin was polymerized and conjugated with pyrene as described previously (26).
Following a final gel filtration step, the pyrene-actin was stored at 2 mg/mL and 4°C in G
buffer (2 mM Tris pH 8.0, 0.2 mM CaCl2, 0.5 mM ATP, and 5 mM DTT). Protein
concentration was determined by A280nm measurements upon denaturation in 8 M guanidine
hydrochloride, using predicted extinction coefficients for each protein (http://us.expasy.org/
tools/protparam.html).
Actin co-sedimentation
Rabbit skeletal muscle actin for co-sedimentation assays was purchased from Cytoskeleton,
Inc. (Denver, CO). EhFormin1 FH2 domain and F-actin co-sedimentation assays were
conducted as previously described for talin (27). Briefly, actin was diluted to 0.4 mg/mL in
buffer containing 5 mM Tris pH 8.0, 0.2 mM CaCl2, 0.2 mM ATP, and 0.5 mM DTT and
polymerized by addition of 50 mM KCl and 2 mM MgCl2, followed by incubation at room
temperature for 1 hr. EhFormin1 fragments were incubated alone or with a 2:1 molar excess
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of polymerized actin in binding buffer (10 mM Tris pH 7.0, 1 mM ATP, 0.2 mM DTT, 1
mM EGTA, 0.1 mM CaCl2, and 2 mM MgCl2) for 1 hour at room temperature. Samples
were centrifuged at 100,000 × g and 20°C for 15 minutes. Proteins in the supernatant and
pellet fractions of each experiment were resolved by SDS-PAGE and stained with
Coomassie Brilliant Blue.
Actin polymerization in vitro
Monomeric pyrene-actin (~20% pyrene labeled, ~80% unlabeled) was diluted to 40 μM in
buffer containing 25 μM Tris pH 7.4 and 5 mM DTT. 25 μL of diluted pyrene-actin (10 μM
final concentration) and various amounts of EhFormin1 fragments and/or EhRho1 were
brought to a volume of 95 μL in S200 buffer (50 mM HEPES pH 8.0, 150 mM NaCl, and 5
mM DTT). Buffer conditions were held constant in all comparison experiments, since ionic
strength and pH are known to influence actin polymerization kinetics (28). Fluorescence of
the pyrene moiety was monitored throughout the experiment at 30-second intervals using a
FluoroLog modular spectrofluorometer (Horiba, Ann Arbor, MI) with excitation and
emission wavelengths of 365 nm and 407 nm, respectively. Following establishment of a
stable baseline fluorescence (~5 minutes), polymerization was initiated by addition of 5 μL
polymerization buffer (1 mM Tris pH 7.4, 500 mM KCl, 20 mM MgCl2, 2 mM ATP, and 5
mM DTT). Polymerization was allowed to proceed for at least 1 hour. The relative rate of
polymerization was estimated by measuring the slope (fluorescence units/second) of the
actin polymerization curve at 50% of the maximal fluorescent signal, as previously
described (28). All slope measurements were averaged across at least 3 replicate
experiments and statistical significance determined by Student’s t-test.
Surface plasmon resonance
SPR-based measurements of protein-protein interactions were performed on the Biacore
3000 of UNC’s Center for Structural Biology (GE Healthcare), as described previously (7).
Approximately 10,000 resonance units (RUs) of purified His6-EhFormin1 GBD-FH3
tandem and 5,000 RUs of His6-EhFormin1 fusion were separately immobilized on a nickel-
NTA biosensor chip (GE Healthcare) using covalent capture coupling as previously
described (29). An empty surface served as a negative control. Experiments were performed
in running buffer containing 50 mM HEPES pH 7.4, 150 mM NaCl, 0.05% NP-40
alternative (Calbiochem), 50 μM EDTA, and 1 mM MgCl2. For assessment of kinetic
binding properties, 3 injections of 5 μM EhRho1·GTPγS were performed at 10 μL/min with
a 300 second dissociation phase. kobs was obtained by fitting the average of three injections
with a single phase exponential association function using GraphPad Prism v5.0. Similarly,
koff was obtained by fitting the average data immediately following the injections with a
single phase exponential dissociation function. Since kobs is dependent on the concentration
of analyte, kon was derived by kon = (kobs − koff)/(analyte concentration). An affinity
constant was derived from the kinetic data by KD = koff/kon. For equilibrium binding
analyses, multiple injections were performed with increasing concentrations of GTPγS-
loaded EhRho1, EhRacC, EhRacD, and EhRacG, and an affinity constant derived as
described previously (7).
Crystallization and structure determination
A complex of EhRho1·GTPγS and the selenomethionine derivative of the EhFormin1 GBD-
FH3 tandem (a.a. 69-418) was assembled by mixing the two proteins at a 1:1 molar ratio to a
total concentration of 15 mg/mL in crystallization buffer (50 mM Tris pH 8.0, 250 mM
NaCl, 2.5% (v/v) glycerol, 5 mM DTT, 50 μM GTPγS, and 1 mM MgCl2) and incubation
for 30 minutes at room temperature. Crystals of EhRho1·GTPγS/EhFormin1 were obtained
by vapor diffusion from hanging drops at 18°C. The protein solution was mixed 1:1 with
and equilibrated against crystallization solution containing 18% PEG 3350, 100 mM Tris pH
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8.5, and 200 mM MgCl2. Clusters of six hexagonal rod crystals grew to ~200 × 100 × 100
μm over 3 days, but diffraction was limited to >3 Å resolution. Crystal clusters were used to
microseed similar crystallization experiments using the method described previously (30).
Microseeded experiments yielded single hexagonal rod crystals (~300 × 150 × 150 μm) over
5 days, exhibiting the symmetry of space group P61 (a = b = 138.6 Å, c = 57.8 Å, α = β =
90°, γ = 120°) and containing one EhRho1/EhFormin1 dimer in the asymmetric unit. For
data collection at 100K, crystals were serially transferred for ~1 minute into crystallization
solution supplemented with 30% (v/v) glycerol in 10% increments and plunged into liquid
nitrogen. Single wavelength (0.9795 Å) anomalous diffraction data were collected at the
GM/CA-CAT 23-ID-B beamline at the Advanced Photon Source (Argonne National
Laboratory). Data were processed using the HKL-2000 program (31). Heavy atom
searching, experimental phasing, and automated model building were performed with
Phenix AutoSol (32). Heavy atom searching identified 13 of 13 possible sites, and
refinement yielded an estimated Bayes correlation coefficient of 51 to 2.6 Å resolution.
After density modification, the estimated Bayes correlation coefficient increased to 58.
~75% of the model was constructed automatically, and the remaining portion was built
manually throughout the refinement. The current model (Table 1) contains a single EhRho1/
EhFormin1 dimer with EhRho1 bound to GTPγS and magnesium. Refinement was carried
out against peak anomalous data with phenix.refine (32), keeping Bijvoet pairs separate,
interspersed with manual model revisions using the program Coot (33). Refinement
consisted of conjugate-gradient minimization and calculation of individual atomic
displacement and translation/libration/screw (TLS) parameters (34). Residues 1-20 and
185-186 of EhRho1 and residues 69-72 and 378-418 of EhFormin1 could not be located in
the electron density. The model exhibits excellent geometry as determined by MolProbity
(35). A Ramachandran analysis of protein residue backbone angles identified 93% favored,
7% allowed, and 0% disallowed. Coordinates and structure factors are deposited in the
RCSB Protein Data Bank (id 4DVG).
Results
E. histolytica Formin1 modulates actin filament formation
The Diaphanous-related formins catalyze actin polymerization through the FH2 domain
(12). To examine the potential interaction of EhFormin1 with actin, two FH2 domain-
containing fragments of this protein were generated and expressed from E. coli: FH2-DAD
(a.a. 731-1182) and FH2 (731-1127) (see Figure S1). To determine whether the EhFormin1
FH2 domain interacts with actin, co-sedimentation assays were performed (27) using rabbit
skeletal muscle-derived filamentous actin. The EhFormin1 fragments FH2-DAD and FH2
were highly soluble alone, but both co-sedimented with polymerized actin (Figure 1A),
suggesting a direct actin/FH2 domain interaction independent of the putative DAD motif.
Mutation of a conserved surface lysine (K964, Figure S2) required for actin binding by other
formin FH2 domains (36) abolished actin co-sedimentation, suggesting a conserved mode of
FH2 domain/actin interaction (Figure 1A). To determine whether the EhFormin1/actin
interaction altered actin polymerization kinetics, in vitro polymerization assays were
performed with pyrene fluorophore-labeled actin (~20% labeled). The FH2 and FH2-DAD
fragments each decelerated actin polymerization in a concentration-dependent fashion
(Figure 1B, C), as observed by the slope of the actin polymerization curve (28). Some
isolated FH2 domains, such as that of Cdc12 in fission yeast, slow overall actin
polymerization in vitro despite a positive effect on actin filament formation in a cellular
context (37). Like Cdc12, the FH2 domain of EhFormin1 may cap actin filament barbed
ends and require an FH1 domain-associated profilin to accelerate polymerization (38).
However, no FH1 domain-containing EhFormin1 fragments could be obtained as a soluble
recombinant protein from E. coli, precluding a direct test of this hypothesis. Relatively high
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concentrations of all EhFormin1 fragments were required to significantly alter actin
polymerization kinetics, likely reflecting a low affinity EhFormin1/actin interaction.
Alignment of the EhFormin1 FH2 domain sequence with Diaphanous-related formins from
other species (36) (28% identity and 48% similarity to yeast Bni1) indicates only moderate
conservation of residues known to participate in the actin interaction (Figure S2). Similarly,
the E. histolytica actin sequence differs significantly from rabbit skeletal muscle actin at
FH2-domain interaction sites (not shown), suggesting that high EhFormin1 fragment
concentrations may be required to overcome cross-species sequence and/or structural
divergence.
EhFormin1 is autoinhibited by N- and C-terminal interactions
Other Diaphanous-related formins are maintained in an inactive conformation by
interactions between the Diaphanous autoinhibitory domain (DAD motif) and a surface of
the Armadillo repeat portion of the FH3 domain, also called the Diaphanous inhibitory
domain (DID) (16, 17). Inspection of the C-terminus of EhFormin1 revealed considerable
sequence divergence from the core DAD motif conserved among other known formins
(MDxLLExL) (Figure 2C). Accordingly, we wondered whether the DID/DAD
autoinhibitory interaction would be conserved in the case of EhFormin1. Surprisingly, the
EhFormin1 FH2-DAD long fragment was seen to interact with the N-terminal GBD-FH3
domain tandem, as determined by surface plasmon resonance (Figure 2A). This
intramolecular interaction required the divergent putative DAD motif, since the FH2 domain
alone did not bind the GBD-FH3 domain tandem (Figure 2A,B). To determine the effects of
the GBD-FH3 domain interaction on FH2 domain-catalyzed actin filament formation, in
vitro polymerization assays were conducted in the presence or absence of a molar excess of
GBD-FH3 tandem protein. Addition of the GBD-FH3 tandem selectively affected the DAD
motif-containing construct, returning the rate of actin polymerization in its presence to one
indistinguishable from actin alone (Figure 2D). These results suggest that the C-terminus of
EhFormin1 forms a DAD motif-dependent interaction with the N-terminal GBD-FH3
domain region that prevents the modulation of actin polymerization rate by the FH2 domain.
Interaction of the EhFormin1 GBD-FH3 domain tandem with EhRho1 reverses
autoinhibition of the FH2 domain
In previous work (7), we demonstrated that EhRho1 binds the GBD-FH3 domain tandem of
EhFormin1 (a.a. 69-445) selectively in its GTPγS-bound, activated conformation. Since
some minor degradation of that particular GBD-FH3 fragment was reported during
expression and purification (e.g., see Fig. 1B of (7)), we generated multiple alternative
constructs containing the GBD-FH3 region, finding that amino acids 69-418 of EhFormin1
were highly stable as a recombinant protein fragment. The residues removed from this
smaller fragment (i.e., a.a. 419-445) correspond to the dimerization domain of mDia1 (20).
The single-celled E. histolytica parasite expresses ~20 Rho family GTPases, raising the
possibility of highly specific interactions between Rho GTPases and their signaling
effectors. The EhFormin1 GBD-FH3 domain tandem (a.a. 69-418) was observed to interact
selectively with EhRho1 to the exclusion of three other Rho GTPases tested (Figure 3A).
Given apparent endoproteolytic sensitivity of its unstructured, proline-rich FH1 domain,
recombinant full length (and thus autoinhibited) EhFormin1 could not be produced and
purified. To circumvent this problem, we produced a construct (hereafter referred to as
“EhFormin1 fusion”) consisting of the N-terminal GBD-FH3 domain tandem and the C-
terminal FH2-DAD fragment, connected by a 40-residue linker to simulate the presumably
flexible FH1 domain (see Figure S1). While either the EhFormin1 fusion or EhRho1·GTPγS
alone had no measurable effect on in vitro actin polymerization, the EhFormin1 fusion/
EhRho1·GTPγS complex was observed to inhibit actin filament formation (Figure 3B) to a
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similar degree as the corresponding FH2-DAD construct (Figure 1C). This finding suggests
that EhRho1 selectively engages the N-terminus of EhFormin1, freeing the C-terminal FH2
domain to regulate actin filament formation. Using SPR, EhRho1·GTPγS was shown to
bind this EhFormin1 fusion protein with ~3 μM affinity (Figure S3).
Structural features of the EhRho1/EhFormin1 complex
The sequence of the GBD-FH3 domain tandem within EhFormin1 is highly divergent
compared to other known Diaphanous-related formins, with mDia1 being the closest
mammalian homolog (Figure 4). EhRho1 also differs significantly from mammalian Rho
GTPases and other E. histolytica Rho GTPases (Figure 4), particularly given its lack of a
signature Rho insert helix (7). We sought a crystal structure of EhRho1 bound to EhFormin1
to allow structure-based comparison with the mammalian RhoC/mDia1 complex and to
elucidate the determinants of a highly selective Rho/effector interaction. Well-diffracting
crystals of EhRho·GTPγS/EhFormin1 GBD-FH3 domain tandem were obtained with aid of
microseeding (see Materials and Methods). Molecular replacement attempts with structural
models of either EhRho1 (PDB id 3REF) or the mDia GBD-FH3 tandem (PDB id 3EG5) did
not produce electron density maps suitable for accurate modeling, likely given the divergent
conformation of the GBD-FH3 domain tandem. A selenomethioine derivative of the
EhFormin1 GBD-FH3 fragment was therefore generated and crystallographic phases
determined by single-wavelength anomalous dispersion (SAD). For data collection and
refinement statistics, see Table 1.
The overall structure of the EhRho1·GTPγS/EhFormin1 complex resembles that of human
RhoC·GppNHp/mDia1 (20) except that the EhFormin1 fragment used for crystallography
(a.a. 69-418) lacks the dimerization domain, and thus lacks the dimeric quaternary structure
seen for mDia1 (Figure 5). The Armadillo repeats of the DID domain in EhFormin1 are
rotated ~40° away from EhRho1 relative to the conformation seen in the mammalian
homolog (Figure 6). EhRho1 engages the EhFormin1 GBD and the N-terminal portion of
the DID Armadillo repeats through its two mobile switch regions and its α3 helix, as also
seen in mammalian homologs (Figure 5). However, the GTPase binding domain of
EhFormin1 differs from that of mDia by a shortened second helix and an elongated α3 helix
with clearly defined and continuous electron density. As a result of a shortened α2 helix, the
GBD of EhFormin1 remains farther away (~4 Å) from the putative DAD-binding site within
the DID (Figure S4) which may indicate a slightly different mechanism of Rho-induced
activation, since the contingently folded GBD of mDia1 is thought to contribute to DAD
displacement by directly obstructing the DAD-binding site of the DID (18). EhFormin1 also
has an elongated α12-α13 loop relative to mDia1 (Figure 5). This loop is near the DAD-
binding site of the DID in mDia1 (18); together with the highly divergent nature of the
putative DAD motif within EhFormin1 (Figure 2), the presence of this elongated loop
suggests that a unique mode of DAD-mediated autoinhibition may exist in the case of
EhFormin1.
The conformation of EhRho1 in the complex is nearly identical with that we have previously
reported (7) of free EhRho1·GTPγS (Cα r.m.s.d. 0.4 Å, PDB id 3REG), and is also similar
to RhoC in the homologous RhoC·GppNHp/mDia1 complex (Cα r.m.s.d. 1.5 Å, PDB id
1Z2C) (Figures 6, S5). The Rho insert helix of RhoC approaches the C-terminal end of the
mDia1 DID (Figures 5B, 6), leading to the hypothesis that a secondary binding site (beyond
the switch region/GBD interaction) may be important for mDia1 activation (14, 20). In
contrast, the lack of this insert helix within EhRho1 and the relative rotation of the
EhFormin1 DID indicate that such a secondary interaction is absent in the E. histolytica
orthologues (Figures 5A, 6). An EhRho1 molecule from the adjacent asymmetric unit is
interposed between the non-uniformly structured β5-α4 loop of EhRho1 and the last
Armadillo repeat of the EhFormin1 DID, raising the possibility that crystal contacts could be
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responsible for the rotation of the DID domain away from EhRho1 relative to the RhoC/
mDia1 complex. However, this is unlikely given the large magnitude of rotation and the
absence of significant contacts between the interposed EhRho1 and the DID domain; crystal
contacts exist only between EhRho1 molecules in adjacent asymmetric units (see Figure S6).
The EhRho1/EhFormin1 interface is dominated by hydrophobic interactions between the
two switch regions of the GTPase and the GBD (Figure 7A). The critical EhRho1 residues at
this interaction site, such as Phe54 of switch 1 and Leu84 of switch 2, are conserved across
the related GTPases (Figure 4A), suggesting that these hydrophobic interactions, while
important for binding, do not necessarily determine the observed specificity of EhFormin1
for EhRho1. The non-conserved Asp91 of EhRho1 is positioned to potentially form ionic
contacts with EhFormin1 α2 helix residues Lys108 and Lys112 (Figure 7A). The EhRho1
α3 helix contacts the first two Armadillo repeats of the EhFormin1 DID domain, primarily
through residues His120 and Tyr121 (Figure 7B). The imidazole ring of His120 is oriented
for a hydrogen bond interaction with Glu151 of EhFormin1. Interestingly His120 and
Tyr121 are conserved in RacD, but not RacC or RacG (Figure 4A), suggesting that these
two interface residues may be important for specificity. Indeed, mutation of EhRho1 His120
to Gln, the analogous residue in EhRacG, drastically reduced affinity for the EhFormin1
GBD-FH3 tandem as measured by SPR (Figure 7D). Finally, the EhRho1 switch 2 residue
Arg83 is inserted into a groove between the GBD and the DID domain, a region of slightly
negative charge as indicated by vacuum electrostatic calculations (Figure 7C). Arg83 is
within hydrogen bonding distance to multiple exposed peptide backbone carbonyl groups in
this region (Phe156 and Arg157; see Figure S7). Arg83 of EhRho1 corresponds to Arg68 of
human RhoC, which engages its formin effector in a strikingly similar fashion (Figure 6B)
and is required for high affinity interaction (18). However, RhoC Arg68 forms hydrogen
bonds with the side chain of mDia N217 while EhRho1 Arg83 is exclusively within
hydrogen-bonding distance of backbone carbonyl groups (Figure 6, S7). This arginine is
also present in EhRacG, but not other Rho family GTPases (Figure 4A), implicating this
particular residue as a likely determinant of specificity for the EhRho1/EhFormin1
interaction. Mutation of EhRho1 Arg83 to the corresponding Gln in EhRacC and EhRacD
drastically reduced affinity for EhFormin1 (KD >100 μM compared to ~3 μM for wild type
EhRho1; Figure 7D).
Discussion
The isolated FH2 domain of EhFormin1 was observed to slow actin polymerization in vitro,
a phenomenon also exhibited by the corresponding domain from fission yeast Cdc12 (37),
suggesting a possibly similar actin barbed-end capping interaction. Other formin regions
mediate interactions with proteins that can also influence its activation state as an agent of
actin polymerization (39). Perhaps the best studied is the interaction of actin-bound profilin
with the proline-rich FH1 domain (40). Profilins can increase the rate of actin filament
elongation by formins, possibly by increasing the local concentration of actin monomers to
be included in the growing filament (15). In the case of fission yeast Cdc12, the FH1 domain
and associated profilin are required, in combination with the FH2 domain, for acceleration
of actin polymerization (38). While in vitro actin polymerization assays with EhFormin1
fragments provide important mechanistic insights into activity of the isolated protein, it is
important to note that the full-length protein in a cellular context is likely also modulated by
subcellular localization and interactions with multiple other proteins. A limitation of the
pyrene actin polymerization assay used in this study is its inability to differentiate the effects
of EhFormin1 on nucleation of new actin filaments versus accelerated elongation of existing
filaments. Nucleation and elongation are catalyzed with varying efficiency among formins
(12), and further studies are thus necessary to elucidate fully the mechanisms by which
EhFormin1 modulates actin polymerization.
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DRFs are commonly autoinhibited by an intramolecular interaction between the N-terminal
DID domain and the C-terminal DAD domain, consisting of a core MDxLLExL motif
followed by a polybasic region (19). However, the C-terminus of EhFormin1 contains a
highly divergent segment (MExAANxG) corresponding to the core DAD motif, suggesting
a potentially unique mode of regulation. Despite poor conservation of the putative DID/
DAD interface, the N- and C-terminal fragments of EhFormin1 were seen to bind one
another in a DAD-dependent fashion, resulting in inhibition of FH2 domain-mediated
modulation of actin polymerization. Furthermore, a fusion protein containing the N-terminal
GBD-FH3 tandem and the C-terminal FH2-DAD tandem mimicked the presumably
autoinhibited state of full-length EhFormin1, having no measureable effect on actin
polymerization kinetics; binding of activated EhRho1·GTPγS to the GBD-FH3 region
reversed the apparent autoinhibition of the EhFormin1 fusion, suggesting that the EhRho1/
EhFormin1 interaction is sufficient to free the FH2 domain for modulation of actin
polymerization.
The crystal structure in this study provides only the second exemplary snapshot of an
interaction between a Rho GTPase and formin effector. Thus a comparison of the E.
histolytica and human Rho/formin complexes reveals consistent structural features that are
conserved across species and likely of shared importance for Rho-mediated activation of
formins, as well as differences that may reflect properties of individual proteins, such as
formin specificity for particular Rho GTPases. Our structural model of the EhRho1/
EhFormin1 complex reveals a similar interface to that of human RhoC/mDia1 despite a
distant evolutionary relationship as evidenced by substantial sequence divergence. The
GTPase binding domain of EhFormin1 is quite similar to that of mDia1, with a predominant
hydrophobic patch engaging the switch regions of EhRho1 (20). Arg83 of EhRho1 projects
into a relatively negatively charged groove between the GBD and DID domains in a manner
highly homologous to Arg68 of RhoC (20). However, the EhRho1 Arg83 residue forms
hydrogen bonds exclusively with backbone carbonyl groups rather than asparagine side
chains, as seen in the mammalian homolog (20). The EhRho1 switch 2 residue Arg83,
together with the buried side chains of His120 and Tyr121 on the α3 helix of EhRho1, are
important determinants of Rho GTPase specificity in binding EhFormin1. EhRacC and
EhRacD lack the critical switch 2 arginine, while EhRacG lacks the histidine-tyrosine
tandem, and all three of these Rac subfamily GTPases are unable to bind EhFormin1.
Furthermore, mutation of EhRho1 residues Arg83 to the corresponding EhRacC/D
glutamine or His120 to the EhRacG-like glutamine each reduced the affinity of EhRho1 for
EhFormin1 by >100-fold. Such strict specificity of Rho GTPase and effector interactions is
likely of particular importance in E. histolytica where at least 19 Rho family GTPases are
apparently expressed in a single cell (7).
Several lines of evidence suggest that the mechanisms of EhFormin1 autoinhibition and its
activation by EhRho1 may differ significantly from that of the well-studied mDia1 homolog
(16, 17). There is poor EhFormin1 sequence conservation in the putative core DAD motif
and DAD-binding surface on the DID, and EhFormin1 has a uniquely elongated α12-α13
loop near the putative DID/DAD interaction site. Furthermore, the GBD of EhFormin1 has a
shortened α2 helix that would not directly obstruct the DAD-binding surface on the DID as
modeled for mDia1 (Figure S4) (18). Finally, EhRho1 lacks a Rho insert helix and does not
approach the C-terminus of the DID domain, indicating that a secondary EhRho1/
EhFormin1 interaction between these two regions does not exist, in contrast with RhoC/
mDia1.
Previous studies of EhFormin1 in the context of E. histolytica trophozoites (21), together
with our findings ((7) and this paper), suggest that an EhRho1/EhFormin1 signaling axis
may be important for formation of complex actin structures within pseudopodia and
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phagocytic and pinocytic vesicles, particularly in response to extracellular cues such as
serum factors. EhFormin1 also apparently exerts effects on trophozoite mitosis and
cytokinesis (21). Interestingly, both EhRho1 and EhFormin1 are enriched in E. histolytica
uropods (41), suggesting that the GTPase/effector pair may also regulate actin
polymerization at the trailing edge during trophozoite migration and/or surface receptor
capping critical for immune response evasion (5). Knowledge of the structural determinants
defining the EhRho1/EhFormin1 interaction, and of its differences from mammalian
GTPase/formin complexes (Fig. 7), should assist in understanding the contributions of this
actin polymerization pathway to E. histolytica infectivity and invasiveness.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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DID Diaphanous inhibitory domain
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Figure 1. The FH2 domain of EhFormin1 modulates actin filament formation
A) Actin co-sedimentation assays demonstrate that the EhFormin1 FH2 domain fragment
(a.a. 731-1127) and the FH2-DAD combination (a.a. 731-1182) both associate with pre-
formed filamentous actin derived from rabbit skeletal muscle. Mutation of the conserved
Lys964 that is critical for other formin FH2/actin interactions abolished co-sedimentation. S
and P represent the soluble and pellet fractions following high-speed centrifugation,
respectively. B) Indicated fragments of EhFormin1, each containing the FH2 domain,
modulate actin polymerization in vitro, as measured by pyrene-actin polymerization assays.
C) The EhFormin1 FH2 and FH2-DAD fragments are both seen to slow actin
polymerization, as quantified by measuring the slope of each fluorescence curve at 50%
complete polymerization. Error bars represent standard error for three or more replicate
experiments. * indicates a statistically significant difference from actin only (p < 0.05).
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Figure 2. EhFormin1 is autoinhibited by N- and C-terminal domain interactions
A) The N-terminal GBD-FH3 domain tandem (a.a. 69-418) of EhFormin1 binds to the C-
terminal FH2-DAD tandem (a.a. 731-1182), but not the FH2 domain alone (a.a. 731-1127)
as determined by surface plasmon resonance. B) Equilibrium binding analyses revealed a
DAD motif-dependent low micromolar affinity interaction with the EhFormin1 GBD-FH3
fragment. C) The DAD motif region, with a core motif (MDxLLExL) highly conserved
among other known Diaphanous-related formins, is divergent in EhFormin1. S.c. indicates
Saccharomyces cerevisiae and D.m. indicates Drosophila melanogaster, while mDia
isoforms are derived from Mus musculus. D) In vitro actin polymerization assays indicate a
DAD-motif dependent interaction between the N- and C-terminal fragments of EhFormin1
that prevents modulation of actin polymerization. Addition of a molar excess of GBD-FH3
domain tandem (100 μM) had no effect on the isolated FH2 domain from EhFormin1 or on
actin alone. However, the GBD-FH3 tandem prevented deceleration of actin polymerization
by the FH2-DAD fragment. Error bars represent standard error for at least 3 replicate
experiments. * indicates a statistically significant difference (p < 0.05) and ‡ indicates an
indistinguishable slope compared to actin only.
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Figure 3. EhRho1 activates EhFormin1 through interaction with the GBD-FH3 domain tandem
A) The GBD-FH3 domain tandem (a.a. 69-418) of EhFormin1, immobilized on a nickel-
NTA biosensor surface, selectively engaged EhRho1·GTPγS to the exclusion of multiple
other Rho family GTPases from E. histolytica, as measured by surface plasmon resonance.
B) The EhFormin1 fusion protein (25 μM) is apparently autoinhibited, having no measured
effect on actin polymerization kinetics in vitro. While EhRho1·GTPγS alone (100 μM) did
not perturb actin polymerization, it was capable of activating the EhFormin1 fusion,
resulting in deceleration of actin polymerization comparable to that of the FH2-DAD
fragment alone (Figure 1B, C). Error bars represent standard error for at least 3 replicate
experiments. * indicates statistical significance (p < 0.05) compared to actin only.
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Figure 4. Sequence comparisons of Rho family GTPases and Diaphanous-related formins
A) The protein sequence of EhRho1 is aligned with three additional E. histolytica Rho
GTPases that do not engage EhFormin1 (Figure 3A). Secondary structure from the
EhRho1·GTPγS/EhFormin1 crystal structure (PDB id 4DVG; this paper) is diagrammed
above the primary sequence. Black dots indicate residues of EhRho1·GTPγS within 1 Å of
EhFormin1 in the complex. B) The protein sequence of EhFormin1 GBD-FH3 domain
tandem is aligned with its closest mammalian homolog, mDia1. Secondary structure from
the EhRho1·GTPγS/EhFormin1 crystal structure (PDB id 4DVG; this paper) is diagrammed
above the primary sequence. Black dots indicate residues in EhFormin1 within 1 Å of
EhRho1·GTPγS in the complex. All alignments were performed with ClustalW2.
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Figure 5. The crystal structure of EhRho1·GTPγS bound to the GBD-FH3 tandem of
EhFormin1
A) EhRho1 (dark green) in its activated state bound to GTPγS (blue sticks) engages
EhFormin1 primarily through its mobile switch regions (light green) and its α3 helix. The
GTPase binding domain (GBD) of EhFormin1 is shown in yellow and the Armadillo repeats
of the DID domain in orange. Magnesium is shown as a yellow sphere. B) The homologous
mammalian complex between RhoC·GppNHp (cyan) and mDia1 (wheat and red) is posed in
a similar configuration (20) (PDB id 1Z2C). EhRho1 lacks a signature Rho insert helix
(highlighted in orange on RhoC) and the EhFormin1 DID domain Armadillo repeats are
rotated away from EhRho1 relative to this mammalian complex. The EhFormin1 GBD-FH3
tandem construct used in this study also lacks the dimerization domain portion of the FH3
domain, as shown in the RhoC/mDia1 complex.
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Figure 6. Structural comparison of EhRho1/EhFormin1 with mammalian RhoC/mDia1
A) The EhRho1·GTPγS/EhFormin1 complex is superimposed with RhoC·GppNHp/mDia1
(PDB id 1Z2C) using the Cα atoms of the respective Rho GTPases, and colored as in Figure
5. The Rho GTPase and GBD domains are similar across species, but the DID domain
exhibits a different conformation, with an ~40° relative rotation of C-terminal Armadillo
repeats. B) The switch 2 arginines, Arg-83 in EhRho1 and Arg-68 in human RhoC, adopt
nearly identical orientations, inserting between the GBD (yellow/wheat) and DID domain
(orange/red). However, Arg-68 of RhoC forms hydrogen bonds with Asn-217 of mDia1 as
well as backbone carbonyl groups, while Arg-83 of EhRho1 exclusively contacts main chain
carbonyl groups.
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Figure 7. Structural determinants of EhRho1/EhFormin1 binding specificity
A) The EhRho1·GTPγS/EhFormin1 interface is dominated by a hydrophobic surface burial
involving the switch regions of EhRho1 (green) and the EhFormin1 GBD (yellow). Key
hydrophobic residues are shown in sticks. EhRho1 Asp91 is also in position to form an ionic
interaction with Lys108 or Lys112 on EhFormin1. B) The α3 helix of EhRho1 (green) also
contributes to the binding interface, with His120 and Tyr121 inserted between the GBD α3
helix (yellow) and the N-terminal portion of the DID domain (orange). The imidazole ring
of His120 is oriented for hydrogen bonding with Glu151 of EhFormin1. C) EhRho1 switch
2 residue Arg83 inserts into a groove between the GBD and DID domains of EhFormin1
(shown as an electrostatic surface). The guanidinium group of Arg83 resides near an area of
relative negative charge (red surface) and is within hydrogen bonding distance of multiple
backbone carbonyl groups (see Figure S7). D) Wild type EhRho1 binds the EhFormin1
GBD-FH3 tandem, as measured by surface plasmon resonance. Mutation of either Arg83 to
the corresponding glutamine in EhRacC and EhRacD or His120 to an EhRacG-like
glutamine resulted in a >100-fold affinity reduction.
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Table 1
Data collection and refinement statistics for the EhRho1·GTPγS/EhFormin1 complex.
EhRho1γGTPγS/EhFormin1




 a, b, c3(Å) 138.6, 138.6, 57.8
 α, β, γ (°) 90, 90, 120
Peak
Wavelength (Å) 0.97954
Resolution (Å) 40.0 – 2.6 (2.63 – 2.60)*
Rmerge (%) 8.5 (58.0)**
I/σI 15.2 (2.1)
Wilson B-factor 65.0
Completeness (%) 98.4 (86.0)
Redundancy 9.6 (6.4)
Refinement
Resolution (Å) 35.7 – 2.6 (2.7 – 2.6)
No. reflections 19211 (2420)











 Bond lengths (Å) 0.010
 Bond angles (°) 1.233
*
Values in parentheses are for highest-resolution shell.
**
All data were collected from a single crystal.
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